Liposomes as Intravenous Solubilizers for Poorly Water‐Soluble Drugs

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-02-04

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/9781118444726.CH2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid analysis by thin-layer chromatography--a review of the current state.

  2011cited by this paper
• Drug transport to brain with targeted liposomes

  2011cited by this paper
• Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.

  2011cited by this paper
• Modeling the Release Kinetics of Poorly Water-Soluble Drug Molecules from Liposomal Nanocarriers

  2011cited by this paper
• Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.

  2011cited by this paper
• Role of phospholipids in the oral and parenteral delivery of poorly water soluble drugs

  2011cited by this paper
• Mifamurtide in osteosarcoma--a practical review.

  2010cited by this paper
• An overview of liposome lyophilization and its future potential.

  2010cited by this paper
• Lipid nanoparticles for the delivery of poorly water‐soluble drugs

  2010cited by this paper
• Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges.

  2009cited by this paper
• Measurement of the membrane curvature preference of phospholipids reveals only weak coupling between lipid shape and leaflet curvature

  2009cited by this paper
• Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases

  2008cited by this paper
• Influence of Incorporation Methods on Partitioning Behavior of Lipophilic Drugs into Various Phases of a Parenteral Lipid Emulsion

  2008cited by this paper
• Liposomal amphotericin B: what is its role in 2008?

  2008cited by this paper
• Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery

  2008cited by this paper
• Cyclodextrins as pharmaceutical solubilizers.

  2007cited by this paper
• Role of Phospholipid Transfer Protein on the Plasma Distribution of Amphotericin B Following the Incubation of Different Amphotericin B Formulations

  2006cited by this paper
• Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma.

  2006cited by this paper
• 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review

  2005cited by this paper
• Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.

  2005cited by this paper
• Perturbation of a lipid membrane by amphipathic peptides and its role in pore formation

  2005cited by this paper
• Solubilizing Excipients in Oral and Injectable Formulations

  2004cited by this paper
• Membrane perturbation induced by interfacially adsorbed peptides.

  2004cited by this paper
• Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration

  2004cited by this paper
• Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins.

  2004cited by this paper
• Pharmacokinetics of paclitaxel-containing liposomes in rats

  2003cited by this paper
• An intravenous formulation decision tree for discovery compound formulation development.

  2003cited by this paper
• Plasma Protein Binding of Amphotericin B and Pharmacokinetics of Bound versus Unbound Amphotericin B after Administration of Intravenous Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate

  2002cited by this paper
• Cholesteryl ester transfer protein facilitates the movement of water-insoluble drugs between lipoproteins: a novel biological function for a well-characterized lipid transfer protein.

  2002cited by this paper
• Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.

  2001cited by this paper
• Liposomal formulations of Cyclosporin A: a biophysical approach to pharmacokinetics and pharmacodynamics.

  2001cited by this paper
• Verteporfin for Age-Related Macular Degeneration

  2001cited by this paper
• Factors involved in the production of liposomes with a high-pressure homogenizer.

  2001cited by this paper
• Verteporfin: a milestone in opthalmology and photodynamic therapy

  2001cited by this paper
• Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.

  2000cited by this paper
• Verteporfin

  2000cited by this paper
• A molecular model for lipid-mediated interaction between proteins in membranes

  2000cited by this paper
• The Use of Fluorescence Resonance Energy Transfer to Study the Disintegration Kinetics of Liposomes Containing Lysolecithin and Oleic Acid in Rat Plasma

  2000cited by this paper
• Photodynamic therapy: a new approach to the treatment of choroidal neovascularization secondary to age-related macular degeneration.

  1999cited by this paper
• Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.

  1999cited by this paper
• Separation and quantitation of phospholipid classes by HPLC.

  1998cited by this paper
• Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs.

  1998cited by this paper
• Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel.

  1998cited by this paper
• The design and development of DaunoXome® for solid tumor targeting in vivo

  1997cited by this paper
• Solvation: how to obtain microscopic energies from partitioning and solvation experiments.

  1997cited by this paper
• Carrier effects on biological activity of amphotericin B

  1996cited by this paper
• Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.

  1996cited by this paper
• Free-energy determinants of alpha-helix insertion into lipid bilayers.

  1996cited by this paper
• Comparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell line.

  1996cited by this paper
• Modifications in plasma lipoprotein concentration and lipid composition regulate the biological activity of hydrophobic drugs.

  1996cited by this paper
• Liposomal Formulations of Cyclosporin A: Influence of Lipid Type and Dose on Pharmacokinetics

  1995cited by this paper
• Chemical hydrolysis of phospholipids.

  1995cited by this paper
• Gamma-Irradiation of Non-Frozen, Frozen, and Freeze-Dried Liposomes

  1995cited by this paper
• Interaction between zinc(II)-phthalocyanine-containing liposomes and human low density lipoprotein.

  1994cited by this paper
• In vitro interaction of zinc(II)-phthalocyanine-containing liposomes and plasma lipoproteins.

  1994cited by this paper
• Large-scale production of liposomes containing monomeric zinc phthalocyanine by controlled dilution of organic solvents.

  1994cited by this paper
• Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE.

  1993cited by this paper
• Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions.

  1993cited by this paper
• Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins

  1993cited by this paper
• The effect of surface charge on the hydrolysis kinetics of partially hydrogenated egg phosphatidylcholine and egg phosphatidylglycerol in aqueous liposome dispersions.

  1993cited by this paper
• Hydrolysis of Partially Saturated Egg Phosphatidylcholine in Aqueous Liposome Dispersions and the Effect of Cholesterol Incorporation on Hydrolysis Kinetics

  1993cited by this paper
• Chemical stability of liposomes: implications for their physical stability.

  1993cited by this paper
• Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs

  1992cited by this paper
• Liposomal and Lipid Formulations of Amphotericin B

  1992cited by this paper
• Dependence on phospholipid composition of the fraction of cholesterol undergoing spontaneous exchange between small unilamellar vesicles.

  1987cited by this paper
• Fraction of cholesterol undergoing spontaneous exchange between small unilamellar phosphatidylcholine vesicles.

  1986cited by this paper
• Critical parameters in freezing of liposomes

  1986cited by this paper
• Effect of saccharides on the freezing and thawing of liposome dispersion.

  1985cited by this paper
• Preclinical safety evaluation of intravenously administered mixed micelles.

  1984cited by this paper
• Effect of amphotericin B on cholesterol-containing liposomes of egg phosphatidylcholine and didocosenoyl phosphatidylcholine. A refinement of the model for the formation of pores by amphotericin B in membranes

  1978cited by this paper
• Untersuchungen über die Größe, Struktur und Dynamik von Gallensäure/Lecithin-Mischmicellen / Size, Structure, and Dynamics of Bile Salt/Lecithin Mixed Micelles

  1977cited by this paper
• Leakage of sucrose from phosphatidylcholine liposomes induced by interaction with serum albumin.

  1977cited by this paper
• NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE.

  1964cited by this paper
• Negatively Stained Lipoprotein Membranes

  1963cited by this paper
• Action of Saponin on Biological Cell Membranes

  1962cited by this paper
• The relation between the binding of sulfonamides to albumin and their antibacterial efficacy.

  1960cited by this paper

• Exploring the Multifaceted Effects of Silymarin on Melanoma: Focusing on the Role of Lipid-Based Nanocarriers

  2024cites this paper
• Drug Delivery Strategies for Poorly Water-Soluble Silymarin

  2020cites this paper
• Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art

  2019cites this paper
• Advanced Nanotechnologies for Enhancing the Bioavailability of Silymarin: A State of the Art

  2019cites this paper
• Investigations of the influence of liposome composition on vesicle stability and drug transfer in human plasma: a transfer study

  2018cites this paper
• Quantitative In Vitro Assessment of Liposome Stability and Drug Transfer Employing Asymmetrical Flow Field-Flow Fractionation (AF4)

  2016cites this paper
• Phyto-liposomes as nanoshuttles for water-insoluble silybin-phospholipid complex.

  2014cites this paper